Early research (Phase 1)UnknownNCT03423992
What this trial is testing
Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas
Who this might be right for
GliomaMalignant Glioma of BrainRecurrence Tumor
Xuanwu Hospital, Beijing 100